The Retinal Implants market is expected to register a significant growth during the forecast period 2020-2027.
Retinal Implants Market Overview:
Over the next several years, the Retinal Implants Market is expected to develop at a healthy rate. In the world of ophthalmology, retinal implants have emerged as a cutting-edge technique. They are used to help those who are partially or completely blind improve their vision. Because the technology is still in its early stages, there is a lot of conjecture about it.
Due to their enormous market potential, investment in retinal implants and prosthesis R&D has grown in recent years. Several private eyecare businesses have entered the fray, concentrating on the development of more effective retinal implants. The majority of retinal implants on the market today are designed to only partially restore usable vision. Vision loss caused by age-related macular degeneration (AMD) and retinitis pigmentosa can be treated with these implants (RP).
This MRFR report offers a thorough analysis of the retinal implants market. The primary objective of the report is to analyze the current market landscape and its future potential. All the relevant parameters have been considered for retinal implants market analysis. The report also includes a discussion on the growth opportunities, drivers and restraints.
Philips Healthcare, Retina Implant AG, Second Sight Medical Products, Inc. Bionic Eye Technologies, Inc., Bionic Vision Australia, VisionCare Ophthalmic Technologies, Inc, Abbott Vascular.
The report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report.
Market Research Future (MRFR) employs a multi-layered analysis module for presenting accurate industry outlook. The combination of primary and secondary research processes for analysis of governing factors and macro-economic indicators of the market. Detailed surveys and interviews are conducted with key opinion makers across the value chain for collection of primary data. Secondary research processes are leveraged for verification of collected data through valuable inputs from SEC filings, white paper references, paid databases, research publications and other credible sources available in public domain. Additionally, top-down and bottom-up approaches are utilized to extrapolate data, which is then verified using a powerful data triangulation technique. These comprehensive research methods ensure accuracy and objectivity of the retinal implants market foresight.
For the scope of the research, MRFR’s report offers a comprehensive segmental analysis of the global retinal implants market for petroleum coke (fuel-grade)Recent Development
Retina Implant AG is the world's leading manufacturer of subretinal implants for the blind and partially sighted. Dr. Eberhart Zrenner and his colleagues founded Retina Implant AG in 2003 with private investors after extensive research with German university hospitals and institutes, which began with a large grant in 1996 and received a grant from the German Federal Ministry of Education and Research. Their goal was to develop the first fully-functioning electronic retinal implant to restore useful vision to the blind.
VisionCare Ophthalmic Technologies, Inc., a developer of innovative visual prosthetic devices for patients with end-stage age-related macular degeneration (AMD), said today that it has raised $31 million in a Series E investment round. Saints Capital took the lead in this round. Pitango Venture Capital, Three Arch Partners, ONSET Ventures, and Newbury Acquisitions Fund/Infinity CSVC Management are new investors, while Giza Ventures, General iFinancial Holdings, and BSI SA are incumbent investors. Elka Nir, Giza's Managing Director and Head of the Life Sciences Sector, will join VisionCare's board of directors as part of the deal.
Retinal Implants Market By Type
Retinal Implants Market By Region
|Market Size||2027: Significant Value|
|CAGR||2020-2027: Substantial CAGR|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Philips Healthcare, Retina Implant AG, Second Sight Medical Products, Inc. Bionic Eye Technologies, Inc., Bionic Vision Australia, VisionCare Ophthalmic Technologies, Inc, Abbott Vascular|
|Key Market Opportunities||New product launches and R&D Amongst major key Players|
|Key Market Drivers||
North America is projected to command the largest share in the retinal implant market.
Excessive clinical trial activities and increasing FDA approvals are adding market growth.
High cost may limit market growth.
End users of retinal implant market include research institutes, ophthalmic clinics, and others.
Different strategies used by market players to create a dominance in the retinal implant market include collaborations, mergers, product development, and strategic alliances.